A carregar...
Circulating tumor cell count during zoledronic acid treatment in men with metastatic prostate cancer: a pilot study
PURPOSE: Recent clinical trials have demonstrated that zoledronic acid (ZOL) significantly prolongs survival in prostate cancer patients undergoing androgen deprivation therapy. This pilot study investigated the influence of ZOL on circulating tumor cell (CTC) counts in prostate cancer patients in a...
Na minha lista:
| Main Authors: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Asian Pacific Prostate Society (APPS)
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4186959/ https://ncbi.nlm.nih.gov/pubmed/25325027 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12954/PI.14056 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|